Ticker: PHAT

Company Overview: Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. The company's key product, VOQUEZNA, has been launched following FDA approvals in late 2023 and early 2024. Phathom has...